Resources Repository
-
OrganizationWeb Portal 2024ISPOR
Founded in 1995 as an international multidisciplinary professional membership society, the International Society for Pharmacoeconomics …
Founded in 1995 as an international multidisciplinary professional membership society, the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) exists to advance the policy, science, and practice of pharmacoeconomics (health economics) and health outcomes research. ISPOR publishes Value in Health, which contains original research articles in the areas of economic evaluation, outcomes research, and conceptual, methodological, and health policy articles. Beyond health economics and outcomes research resources, tools of ISPOR include strategic initiatives, publications, and member…
Priority Setting/Ethics | Preferences/Values | Health/Medicine | Policy/Regulation | Costing Methods | Health Outcomes | Value of Information | Mathematical Models | Cost-Effectiveness Analysis | Technology Assessment | Operations Research | Infectious Diseases | Maternal/Reproductive Health | Child/Nutrition | Chronic Disease/Risk | Health Systems | Business/Industry | Economics/Finance | Science/Technology | Global -
ReviewPublication 2016Economic Dimensions of Noncommunicable Diseases in Latin America and the Caribbean
This companion volume to Disease Control Priorities, Third Edition (DCP3), explores the impact of noncommunicable diseases …
This companion volume to Disease Control Priorities, Third Edition (DCP3), explores the impact of noncommunicable diseases (NCDs) on development and economic growth in the countries of Latin America and the Caribbean (LAC). This collection of manuscripts examines the complex interplay among NCDs, health expenditures and financial investments in health, poverty, and inequities, using up-to-date information and evidence from the LAC region. There is compelling proof that NCDs are a major and growing problem for low- and…
Priority Setting/Ethics | Health/Medicine | Policy/Regulation | Mental Health | Costing Methods | Cost-Effectiveness Analysis | Technology Assessment | Child/Nutrition | Chronic Disease/Risk | Social Determinants | Health Systems | Economics/Finance | Food/Agriculture | Latin America & Caribbean -
ReviewPublication 2016Strengthening Cost-Effectiveness Analysis for Public Health Policy
Many important opportunities to improve health lie outside the health sector and involve improving the …
Many important opportunities to improve health lie outside the health sector and involve improving the conditions in which we live and work: safe design and maintenance of roads, bridges, train tracks, and airports; control of environmental pollutants; occupational safety; healthy buildings; a safe and healthy food supply; safe manufacture of consumer products; a healthy social environment; and others. Faced with the overwhelming array of possibilities, U.S. decision makers need help identifying those that can contribute the…
Priority Setting/Ethics | Preferences/Values | Health/Medicine | Policy/Regulation | Costing Methods | Cost-Effectiveness Analysis | Social Determinants | Environmental Health | Health Systems | Climate/Environment | Economics/Finance | Food/Agriculture | North America -
ReviewPublication 2016Using Economic Evidence to Set Healthcare Priorities in LMIC
Policy makers in low-income and lower-middle-income countries (LMICs) are increasingly looking to develop ‘evidence-based’ frameworks …
Policy makers in low-income and lower-middle-income countries (LMICs) are increasingly looking to develop ‘evidence-based’ frameworks for identifying priority health interventions. This paper synthesizes and appraises the literature on methodological frameworks – which incorporate economic evaluation evidence – for the purpose of setting healthcare priorities in LMICs. A systematic search of Embase, MEDLINE, Econlit and PubMed identified 3968 articles with a further 21 articles identified through manual searching. A total of 36 papers were eligible for inclusion.…
Priority Setting/Ethics | Benefit-Cost Analysis | Health/Medicine | Policy/Regulation | Cost-Effectiveness Analysis | Technology Assessment | Health Systems | Economics/Finance | Government/Law | Sub-Saharan Africa | Middle East & North Africa | Latin America & Caribbean | Asia & Pacific -
ReviewPublication 2001Modeling for Health Care and Other Policy Decisions: Uses, Roles and Validity
This is a review article of the role of modeling approaches to guide decision making …
This is a review article of the role of modeling approaches to guide decision making in health care and other domains. The role of models to support recommendations on the cost-effective use of medical technologies and pharmaceuticals is controversial. At the heart of the controversy is the degree to which experimental or other empirical evidence should be required prior to model use. The authors argue that the controversy stems in part from a misconception that…
Evidence Synthesis | Priority Setting/Ethics | Health/Medicine | Policy/Regulation | Mathematical Models | Technology Assessment | Environmental Health | Health Systems | Business/Industry | Climate/Environment | Economics/Finance | Energy/Engineering | Government/Law | North America -
ReviewPublication 1982Decision Analysis: An Overview
This article, written for the non-decision analyst, describes what decision analysis is, what it can …
This article, written for the non-decision analyst, describes what decision analysis is, what it can and cannot do, why one should care to do this, and how one does it. Keeney describes decision analysis as "a formalization of common sense for decision problems which are too complex for informal use of common sense." He provides a more technical definition also, describing decision analysis as "a philosophy, articulated by a set of logical axioms, and a methodology…
Preferences/Values | Decision Theory | Health/Medicine | Policy/Regulation | Decision Analysis | Business/Industry | Economics/Finance | Energy/Engineering | Government/Law | Military/Defense | Science/Technology -
ReviewPublication 2018Patient Variability Seldom Assessed in Cost-Effectiveness Studies
This article in Medical Decision Making reviews 200 articles published in 2014 to determine whether …
This article in Medical Decision Making reviews 200 articles published in 2014 to determine whether each cost-effectiveness analysis (CEA) study reported subgroup results and collected data on the defining characteristics of these subgroups. Since estimates can vary across patient subgroups when characteristics are influenced by preferences, outcome risks, treatment effectiveness, life expectancy, or associated costs it can be important to track and report these differences. The authors identified whether any of the CEA subgroup results…
Preferences/Values | Health/Medicine | Policy/Regulation | Cost-Effectiveness Analysis | Social Determinants | Health Systems | Global -
OrganizationWeb Portal 2024AcademyHealth
AcademyHealth formed in June 2000, from a merger between the Alpha Center, a health policy resource center …
AcademyHealth formed in June 2000, from a merger between the Alpha Center, a health policy resource center providing analysis, facilitation, education, and training, and the Association for Health Services Research, a non-profit professional society for those with a commitment to health services research, whose mission involved educating consumers and policymakers about the importance of health services research, securing funding for the field, and providing networking and professional development opportunities. AcademyHealth acts as a broker of information, bringing together…
Evidence Synthesis | Health/Medicine | Policy/Regulation | Health Outcomes | Health Systems | North America -
OrganizationWeb Portal 2024International Decision Support Initiative (iDSI)
The International Decision Support Initiative (iDSI) is a global network of health, policy and economic …
The International Decision Support Initiative (iDSI) is a global network of health, policy and economic expertise, working to achieve Universal Health Coverage and The Health Sustainable Development Goal (SDG 3). They are committed to robust evidence, analysis and decision-making that policymakers, funders and researchers can use to balance trade-offs between different policy options and model potential results to make the best choice available. They support countries to make better decisions about how much public money…
Priority Setting/Ethics | Health/Medicine | Policy/Regulation | Costing Methods | Health Outcomes | Cost-Effectiveness Analysis | Technology Assessment | Health Systems | Economics/Finance | Government/Law | Global